Portfolio
Zafrens
“Zafrens is developing an ultra-high throughput single cell platform to isolate, image, run assays on, and sequence millions of individual single cells per day. This platform allows for full characterization of diverse cell populations, as well as ties molecular profiles (DNA, RNA, protein) to cell phenotype & function. Further, Zafrens’ platform individually drugs each cell and reads out the full molecular / functional impact across millions of compounds in parallel - enabling a new paradigm in drug discovery.”
Founder: Swamy Vijayan
Location: San Diego, California
Category: Life Sciences / Services / Single Cell
Company Stage: Series A
Co-Investors: Prime Movers Lab & Blueyard
